Matrix Therapy Company in Regenerative Medecine

Home
About us
Our Science
Our Products
Events & News
Contact

Regional Sales Manager SWIFT

7 Feb 2019 Stéphane Barritault

Steering Board

Nicolas WILLARD

Search

Recent Posts

A Retrospective Self-Controlled Study Evaluating the Prophylactic Effects of CACIPLIQ20 on Postsurgical Scars
Apr, 2023 – Publication
Dec, 2022 – Clinical
A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis
Effect of a Matrix Therapy Agent on Corneal Epithelial Healing After Standard Collagen Cross-linking in Patients With Keratoconus: A Randomized Clinical Trial

Recent Comments

Archives

April 2023
January 2023
May 2022
March 2022
February 2022
November 2021
October 2021
August 2021
June 2021
February 2019

Categories

Cacipliq 20
CLERAPLIQ
DERMAPLIQ
Management Team
Media Publications
News
Steering Board

Meta

Log in
Entries feed
Comments feed
WordPress.org